News of Interest
01 November 2011

Prioritising for HIV Investment

Renowned health economist Alan Whiteside delivered a public lecture entitled “Economics and HIV: Costs and Consequences” at the University of KwaZulu-Natal in Durban on 12 October 2011. After reflecting on the past 30 years of HIV and AIDS science, politics and socio-economic challenges in South Africa, he cited projections reported last year in the AIDS2031 project conducted by CEGAA and the Results for Development Institute.

The AIDS2031 data illustrate the severity of South Africa’s continuing epidemic, the prospect of increased numbers on treatment, and the anticipated demands on the national fiscus and health services inherent in this scenario. While defending the biomedical evidence and moral imperative that form the basis for life-long ARV provision, Whiteside argued for equally heightened attention to prevention behaviour, so as to reduce the macro-economic impact of supporting three million people on HIV treatment.

Read more

AIDS FundingBudget AdvocacyEconomic Governance
All News of Interest All CEGAA in the News



► 2016
► 2013
► 2012
▼ 2011
► 2010
► 2006

Add a Comment

We value your feedback on the information we provide and the projects we take part in. Please leave a comment or question for our team, or use this space to start a discussion with other readers. Please respect fellow site users and do not post inappropriate or non-relevant comments. All comments are moderated before they appear on the site.

Submit a Comment

Your Name:
Email Address: (optional - never shown)
To stop spam, please answer the following sum using only digits (eg: 3, not "three"): seven + four =
Submit Your Comment